Table 1 Descriptive statistics on patients and PAVMs
From: Evaluation of percutaneous transcatheter embolization for pulmonary arteriovenous malformations
Patient (n = 43) | |
|---|---|
Age (years): mean ± SD | 42 ± 14 |
Range | 19–71 |
Sex (male: female ratio), n | 17/26 |
Number of patients with HTT, n/N1 (%) | 23/43 |
Presentation: n/N1 (%) | |
Hypoxemia | 28/43 |
Dyspnoea | 8/43 |
Cyanosis | 7/43 |
Cerebral abscess | 3/43 |
Stroke | 2/43 |
Migraine | 9/43 |
Haemorrhage | 5/43 |
PAVMs number (total): n/N1 (%) | |
Single | 15/43 |
Double | 12/43 |
More than two | 16/43 |
PAVMs location: n/N2 (%) | |
Right upper lobe | 9/101 |
Right middle lobe | 20/101 |
Right lower lobe | 33/101 |
Left upper lobe | 8/101 |
Left lower lobe | 31/101 |
Treated PAVMs number (N3/N2) | 72/101 |
Treated PAVMs feeding artery (mm) | 7.9 ± 2.9 |
Range | 3.5–14.0 mm |
Embolization materials: n/N3 (%) | |
Coil | 25/72 |
Vascular plug | 21/72 |
Coil and vascular plug | 26/72 |
Complications: n/ N1 (%) | |
Pleuritic chest pain | 5/43 |
Pulmonary thrombosis and embolism | 1/43 |
Follow-up period (months): mean ± SD | 25.02 ± 9.44 |
Range | 12–49 |